Amgen Patent definition

Amgen Patent. 2 1.6 "Amgen Technology" 2 1.7 "BLA" 2 1.8 "CMC" 2 1.9 "Combination Product" 2 1.10 "Commercialize" or "Commercialization" 2 1.11 "Commercially Reasonable Efforts" 2 1.12 "Confidential Information" 2 1.13 "Control" 2 1.14 "Default" 2 1.15 "Directly Competitive Product" 2 1.16 "Dollar" 2 1.17 "Drug Approval Application" 2 1.18 "Existing License" 3 1.19 "Existing License Patents" 3 1.20 "Existing Licensor" 3 1.21 "FDA" 3 1.22 "Force Majeure" 3 1.23 "GAAP" 3 1.24 "Infergen" 3 1.25 "IND" 3 1.26 "Interferon alfacon-1" 3 1.27 "Licensed Product" 3 1.28 "Losses" 3 1.29 "Net Sales" 3 1.30 "Ongoing Clinical Trials" 3 1.31 "Other Licensee" 3 1.32 "Patent" 3 1.33 "PEG Know-How" 4 1.34 "PEG Patent" 4 1.35 "PEG Program" 4 1.36 "PEG-Infergen Product" 4 1.37 "Phase III Clinical Trial" 4 1.38 "Phase IV Clinical Trial" 4 1.39 "Planning Period Date" 4 1.40 "Regulatory Approval" 4 1.41 "Regulatory Authority" 4 1.42 "Royalty" or Royalties" 4 1.43 "Sublicensee" 4 1.44 "Supply Terms" 4 1.45 "Term" 4 1.46 "Territory" 4 1.47 "Third Party" 4 1.48 "Trademark" 4 1.49 "Valid Claim" 5
Sample 1
Amgen Patent means [***]
Sample 1
Amgen Patent means [*]
Sample 1

Examples of Amgen Patent in a sentence

  • Amgen shall have the sole right to initiate any infringement proceedings or take other appropriate actions against an Infringement of any Amgen Patent or to defend against any challenge of an Amgen Patent.

  • Notwithstanding the foregoing, to the extent any such recoveries are obtained with respect to Amgen Patents, the amount payable to Xencor with respect to that portion of such recovery attributable to an Amgen Patent (after reimbursement of litigation expenses) shall be reduced by […***…]%.

  • During the Term, Amgen (and, subject to Section 13.8, its Affiliates): (a) shall not make, use, sell, offer for sale, import, Develop or commercialize any Restricted Antibody; and (b) shall not license or authorize, under any Amgen Patent or Joint Patent, any Third Party to, make, use, sell, offer for sale, import, Develop or commercialize any Restricted Antibody; except, in each case, for activities with respect to Compounds hereunder.

  • Subject to Section 8.4(f), Amgen shall have the sole right to initiate any infringement proceedings or take other appropriate actions against an Infringement of any Amgen Patent in the Territory.

  • Notwithstanding the foregoing, any dispute, controversy or claim relating to the scope, validity, enforceability or infringement of any United States patent application or patent within Amgen Patent Rights or Joint Patent Rights shall be submitted to a court of competent jurisdiction in the State of California.

  • This Agreement and its effect are subject to and shall be construed and enforced in accordance with the law of the State of New York, without regard to its conflicts of laws, except as to any issue which depends upon the validity, scope or enforceability of any Amgen Patent, EnteraBio Patent or Collaboration Patent, which issue shall be determined in accordance with the laws of the country in which such patent was issued.

  • This Agreement shall become effective on the Effective Date and shall remain in full force and effect, unless earlier terminated pursuant to this Article 16, until the later of: (a) the expiration of the Amgen Patent Rights or (b) the date on which there are no Collaboration Products being Developed or Commercialized by the Parties.

  • Notwithstanding the above Section 13.2, as between the Parties, any dispute, controversy or claim relating to the scope, validity, enforceability or infringement of any Amgen Patent Rights or Joint Patent Rights or of any Product Trademark shall be submitted to a court of competent jurisdiction in the Territory in which such Patent Rights or Trademark rights were granted or arose.

  • Upon receipt of the Budget report responses related to actual expenditure calculations and figures from the Business Office Budget Analyst, the Grants Specialist provides the budget expenditure narrative explanation of each type of expense as required by the report.

  • In fact, we will show that a suitably defined product of selection functions calculates optimal strategies.Example 2.2.3. In Example 2.2.1 above, the optimal outcome w of the game tells which of Eloise and Abelard has a winning strategy.


More Definitions of Amgen Patent

Amgen Patent means any issued patent held by Amgen issuing from a patent application having as its earliest filing date a date no earlier than the Patent License Effective Date, which patent claims the generation, screening or use of any Fusion Protein or library displayed on any cell, spore or virus where such generation, screening or use (a) results in the identification or discovery of a Licensed Intermediate, and (b) the practice of which would, but for the licenses granted hereunder, infringe one or more claims of the Licensed Patents.
Sample 1

Related to Amgen Patent

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Patent Rights means the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region, including all provisional applications, substitutions, continuations, continuations-in-part, divisions, renewals, all letters patent granted thereon, and all reissues, re-examinations and extensions thereof, and all foreign counterparts of any of the foregoing.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Licensee Patents means all Patents that (i) claim any inventions developed by or on behalf of Licensee in the Development, manufacture or Commercialization of any of the Products in the Field pursuant to this Agreement, or (ii) are Controlled by Licensee or its Affiliates during the Term and claim or cover any of the Products (including composition of matter, methods of manufacturing and methods of treatment or use).”

  • Licensed Patent Rights means:

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Product Patents means any Patent Controlled or owned by Quoin in the Territory that, absent the license in Section 2.1, would be infringed by the importation, sale, or use of the Product in the Territory by a third party.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Joint Patents has the meaning set forth in Section 8.1.

  • Regents' Patent Rights means REGENTS' rights in (a) the patent and patent applications expressly identified in Appendix C and their foreign counterparts;

  • Valid Patent Claim means a claim of an issued and unexpired Patent which has not been disclaimed, revoked, held unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise.

  • Company Patents means Patents owned by the Company or used or held for use by the Company in the Business.

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Valid Claim means a claim of an issued and unexpired Patent that (i) has not been revoked or held unenforceable or invalid by a decision of a court or other Governmental Entity of competent jurisdiction from which no appeal can be taken or has been taken within the time allowed for appeal and (ii) has not been abandoned, disclaimed, denied, or admitted to be invalid or unenforceable through reissue or disclaimer or otherwise in such country.

  • Patent Application means an application for patent protection for a CRADA Subject Invention with the United States Patent and Trademark Office (“U.S.P.T.O.”) or the corresponding patent-issuing authority of another nation.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Product Infringement has the meaning set forth in Section 9.4(a).

  • Licensed IP means the Licensed Patents and the Licensed Know-How.

  • Assigned Patents means all Patents issued to, or for which applications are pending in the name of, Holdings or any of its Subsidiaries and (a) assigned to IP Hold-Co in accordance with the Patent Assignment Agreement, including without limitation any Patents described on Schedule 5.17(a) or that are thereafter acquired by, or filed in the name of, Holdings or any of its Subsidiaries, including Patents that are the subject of Section 6.18.

  • Joint IP means Joint Know-How and Joint Patents.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.